Skip to main content
Fig. 2 | Respiratory Research

Fig. 2

From: Real-world effectiveness of early intervention with fixed-dose tiotropium/olodaterol vs tiotropium in Japanese patients with COPD: a high-dimensional propensity score–matched cohort analysis

Fig. 2

Patient selection for the prespecified study period (1 April 2015 to 31 March 2019). aTriple therapy included any fixed-dose or concurrent use of LAMA, LABA, and ICS. BL baseline, COPD chronic obstructive pulmonary disorder, hdPS high-dimensional propensity score, ICS inhaled corticosteroid, LABA long-acting β2-agonist, LAMA long-acting muscarinic antagonist, MDV Medical Data Vision Co., Ltd. database, Tio tiotropium, Tio/Olo tiotropium/olodaterol

Back to article page